XML 97 R25.htm IDEA: XBRL DOCUMENT v3.25.1

Stockholders’ Equity (Tables)

3 Months Ended

Mar. 31, 2025

Accumulated Other Comprehensive Income (Loss) [Line Items]

Summary of Option Activity

A summary of stock option activity under the Company’s 2021 Equity Incentive Plan for the three months ended March 31, 2025 and 2024 is presented below:

Summary of Option Activity 

		Number of Shares				Weighted Average Exercise Price				Total Intrinsic Value				Weighted Average Remaining Contractual Life (in years)
Options outstanding as of December 31, 2024			1,302,500			$	1.96			$	804,300				1.7
Employee options granted			1,427,068				2.47				-				6.6
Options outstanding as of March 31, 2025			2,729,568			$	2.22			$	6,750				4.1
Options vested and exercisable as of March 31, 2025			2,453,318			$	2.26			$	1,688				4.1

		Number of Shares				Weighted Average Exercise Price				Total Intrinsic Value				Weighted Average Remaining Contractual Life (in years)
Outstanding as of December 31, 2023			1,200,000			$	2.12			$	8,700				2.4
Employee options granted			-				-				-				-
Employee options forfeited			-				-				-				-
Outstanding as of March 31 ,2024			1,200,000			$	2.12			$	17,150				2.1
Options vested and exercisable as of March 31, 2024			1,145,000			$	2.15			$	1,300				2.0

Schedule of Restricted Stock Units

Schedule of Restricted Stock Units 

Market Cap Vesting Thresholds
$ 100 million		$ 150 million				$ 300 million
50,000			50,000				50,000

Summary of Restricted Stock

The following table summarizes RSU activity under the 2021 Plan for the three months ended March 31, 2025:

Summary of Restricted Stock 

		Number of Restricted Stock Units				Weighted Average Grant Date Fair Value
Nonvested as of December 31, 2024			1,140,971			$	3.27
Granted			150,000				2.47
Vested			-				-
Vested and converted to restricted common shares			(1,170,834	)			3.05
Forfeited			(120,137	)			4.37
Nonvested as of March 31, 2025			-			$	-

Schedule of Stock-based Compensation Expense

Stock-based compensation expenses are allocated among general and administrative expenses, compensation expenses and cost of revenues. Stock-based compensation expense for the three months ended March 31, 2025 and 2024 was as follows:

Schedule of Stock-based Compensation Expense 

		2025				2024
		For the Three Months Ended March 31,
		2025				2024
Employee stock option awards		$	55,212			$	9,280
Employee restricted stock unit awards			151,958				239,146
Forfeiture of employee restricted stock unit and share awards			(262,058	)			-
Non-employee restricted stock awards			37,503				25,003
Stock-based compensation		$	(17,385	)		$	273,429

Summary of Warrant Activity

The following is a summary of warrant activity for the three months ended March 31, 2025:

Summary of Warrant Activity 

		Number of Warrants
Outstanding as of December 31, 2024			712,500
Expiration of warrants			-
Outstanding as of March 31, 2025			712,500

Common Stock [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Summary of Restricted Stock

The following table summarizes restricted Common Stock activity under the 2021 Plan for the three months ended March 31, 2025:

Summary of Restricted Stock 

		Number of Restricted Shares of Common Stock
Outstanding and nonvested as of December 31, 2024			270,794
Converted from restricted stock units			1,170,834
Forfeited			(129,327	)
Outstanding and nonvested as of March 31, 2025			1,312,301

Restricted Stock [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Schedule of Weighted-Average Assumptions Used to Estimate Fair Value

Schedule of Weighted-Average Assumptions Used to Estimate Fair Value 

		January 1, 2025
Vesting Hurdle Price			$ 5.26 - $15.79
Term (years)			2.00
Expected stock price volatility			92.70	%
Risk-free rate of interest			4.25	%

2021 Equity Incentive Plan [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Schedule of Weighted-Average Assumptions Used to Estimate Fair Value

Schedule of Weighted-Average Assumptions Used to Estimate Fair Value 

		For the Three Months Ended March 31,
		2025				2024
Exercise price		$	2.47			$	-
Term (years)			5.00				-
Expected stock price volatility			113.66	%			0.00	%
Risk-free rate of interest			4.16	%			0.00	%

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-4

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481674/830-30-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 17
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481694/830-30-45-17

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 20
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481694/830-30-45-20

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 20
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481694/830-30-45-20

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 20
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481694/830-30-45-20

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 20
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481694/830-30-45-20

+ Details

Name:	us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested restricted stock shares.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Subparagraph (c)
-Paragraph 2
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of employee stock purchase plan activity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-1

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_PlanNameAxis=BTCS_TwoThousandAndTwentyOneEquityIncentivePlanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: